Sign in
4

Changes in Ownership

BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001144204-19-043047

Director sold 13,332 shares at $3.67 ($48,891)

  • Director acquired 13,332 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ARBEL IRIT · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-08-28 Exercise or conversion : show line 1 in the form +6,666 $2.25 $14,999 162,499 D
2019-08-28 Exercise or conversion : show line 2 in the form +6,666 $2.25 $14,999 169,165 D
2019-08-28 Sale : show line 3 in the form −13,332 $3.67 $48,891 155,833 D
Open-market sales · 13,332 sh · avg $3.67 · $48,891

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2019-08-28 Exercise or conversion : show line 4 in the form Stock Option (right to buy) −6,666 0 D
2019-08-28 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −6,666 0 D
Loading xslF345X03/tv528639_4.xml…